Patents Assigned to Whiteland Institute for Biomedical Research
  • Use of FOXC2 in diagnosing, preventing and treating cancer metastasis
    Patent number: 8088590
    Abstract: The invention relates to methods and compositions for inhibiting metastasis, such as by inhibiting FOXC2 expression or activity. The invention further relates to methods of prognosticating, diagnosing, and assisting in the diagnosis of metastasis in an individual, or of determining the metastatic potential of a tumor. The invention further relates to methods of identifying agents which inhibit metastasis.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: January 3, 2012
    Assignee: Whiteland Institute for Biomedical Research
    Inventors: Sendurai Mani, Jing Yang, Robert A. Weinberg